Exscientia PLC at Goldman Sachs Global Healthcare Conference Transcript
Excellent. Good morning, everybody, and welcome to our second day of the Goldman Sachs Healthcare Conference. My name is Chris Shibutani. I'm a member of the biopharmaceuticals equity research team. Together with my colleagues, we're very excited to welcome one of the new fresh names, fresh faces on the public company stage in a very dynamic space, the advancements and really the next phase of R&D with the invocation of artificial intelligence, Exscientia, really amongst the many exciting companies very much at the forefront.
We're very pleased to have join us here, CEO, Andrew Hopkins; and someone who we would love to learn more about as well to give voice, Dave Hallett, who's the Chief Operating Officer, and as I recently learned has been with the company for a few years. It's a young company.
Thank you very much for joining us.
Pleasure to be here.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
